Brent Sabatini sold $4K of Vir Biotechnology, Inc. (VIR) stock

Brent Sabatini, SVP, Chief Accounting Officer of Vir Biotechnology, Inc. (VIR), sold 379 shares of VIR stock worth $4K, per an SEC Form 4 filed Jun 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 1, 2026, 1 day before it was made public.

VIR has moved +20.5% since the trade date, from $9.03 to $10.88 (Sep 21, 2026 close).